- 全部删除
您的购物车当前为空
CCG-203971 是一种Rho/MRTF/SRF 通路抑制剂,具有潜在的抗转移作用。它有效靶向 RhoA/C 激活的 SRE 荧光素酶,IC50为 6.4 μM。它抑制 PC-3 细胞迁移,IC50为 4.2 μM。


为众多的药物研发团队赋能,
让新药发现更简单!
CCG-203971 是一种Rho/MRTF/SRF 通路抑制剂,具有潜在的抗转移作用。它有效靶向 RhoA/C 激活的 SRE 荧光素酶,IC50为 6.4 μM。它抑制 PC-3 细胞迁移,IC50为 4.2 μM。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 126 | In stock | |
| 5 mg | ¥ 246 | In stock | |
| 10 mg | ¥ 463 | In stock | |
| 25 mg | ¥ 913 | In stock | |
| 50 mg | ¥ 1,490 | In stock | |
| 100 mg | ¥ 2,380 | In stock | |
| 500 mg | ¥ 5,650 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 273 | In stock |
CCG-203971 相关产品
| 产品描述 | CCG-203971 is an inhibitor of SRE activation in the prostate cancer cell line PC-3 (IC50: 6.4 μM), with 87% inhibition of SRE activation achieved at 100 μM. This compound also inhibits PC-3 cell migration (IC50: 4.2 μM), as determined by a scratch wound assay. CCG-203971(CCG203971) causes no cytotoxicity when evaluated by the WST-1 assay. It is well tolerated in normal mice up to doses of 100 mg/kg given intraperitoneally over five days. |
| 靶点活性 | SRE.L:0.64 μM |
| 别名 | CCG203971 |
| 分子量 | 408.88 |
| 分子式 | C23H21ClN2O3 |
| CAS No. | 1443437-74-8 |
| Smiles | Clc1ccc(NC(=O)C2CCCN(C2)C(=O)c2cccc(c2)-c2ccco2)cc1 |
| 密度 | 1.305 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 50 mg/mL (122.29 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容